{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:07:06Z","timestamp":1790129226190,"version":"4.0.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005632","name":"National Centre for Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005632","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015077","name":"Jagiellonian University Medical College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015077","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bioorg.2024.107755","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T17:14:14Z","timestamp":1725038054000},"page":"107755","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Antibacterial and antibiofilm agents in the group of xanthone derivatives with piperazine moiety active against drug-resistant Helicobacter pylori strains"],"prefix":"10.1016","volume":"153","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7103-5292","authenticated-orcid":false,"given":"Dorota","family":"\u017belaszczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8655-1651","authenticated-orcid":false,"given":"Aneta","family":"Chmiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4162-4760","authenticated-orcid":false,"given":"Agnieszka","family":"Gunia-Krzy\u017cak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henryk","family":"Marona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3117-8894","authenticated-orcid":false,"given":"Pawe\u0142","family":"Krzy\u017cek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinga","family":"Dworak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0533-2130","authenticated-orcid":false,"given":"Iwona","family":"Skiba-Kurek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7188-1077","authenticated-orcid":false,"given":"El\u017cbieta","family":"Karczewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9825-4302","authenticated-orcid":false,"given":"Justyna","family":"Popi\u00f3\u0142","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"P\u0119kala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"\u017bmudzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0702-7137","authenticated-orcid":false,"given":"Magdalena","family":"Zi\u0105bka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2756-3340","authenticated-orcid":false,"given":"Karolina","family":"Klesiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bioorg.2024.107755_b0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3748\/wjg.v12.i2.181","article-title":"Causal role of Helicobacter pylori infection in gastric cancer","volume":"12","author":"Ando","year":"2006","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.bioorg.2024.107755_b0010","unstructured":"Schistosomes, liver flukes and Helicobacter pylori, IARC Monogr. Eval. Carcinog. Risks Hum. 61 (1994) 1\u2013241."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107755_b0015","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.07.007","article-title":"Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in world health organization regions","volume":"155","author":"Savoldi","year":"2018","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.bioorg.2024.107755_b0020","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of Helicobacter pylori infection\u2013the Maastricht IV\/ Florence Consensus Report","volume":"61","author":"Malfertheiner","year":"2012","journal-title":"Gut"},{"issue":"Suppl 1","key":"10.1016\/j.bioorg.2024.107755_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1083-4389.2004.00248.x","article-title":"Epidemiology of Helicobacter pylori infection","volume":"9","author":"Perez-Perez","year":"2004","journal-title":"Helicobacter"},{"key":"10.1016\/j.bioorg.2024.107755_b0030","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2022-327745","article-title":"Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report","author":"Malfertheiner","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.bioorg.2024.107755_b0035","doi-asserted-by":"crossref","unstructured":"E. Karczewska, K. Klesiewicz, P. Nowak, et al., Empirical versus targeted treatment of helicobacter pylori infections in southern Poland according to the results of local antimicrobial resistance monitoring. Trends in Helicobacter pylori Infection, InTech, 2014. DOI: 10.5772\/57387.","DOI":"10.5772\/57387"},{"issue":"5","key":"10.1016\/j.bioorg.2024.107755_b0040","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3390\/antibiotics9050228","article-title":"High Primary Antibiotic Resistance of Helicobacter pylori Strains Isolated from Pediatric and Adult Patients in Poland during 2016\u20132018","volume":"9","author":"Krzy\u017cek","year":"2020","journal-title":"Antibiotics (basel)"},{"issue":"7","key":"10.1016\/j.bioorg.2024.107755_b0045","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.3390\/jcm8071071","article-title":"Antibiotic resistance and genotypes of Helicobacter pylori strains in patients with gastroduodenal disease in southeast Poland","volume":"8","author":"Korona-Glowniak","year":"2019","journal-title":"J. Clin. Med."},{"issue":"23","key":"10.1016\/j.bioorg.2024.107755_b0050","doi-asserted-by":"crossref","first-page":"9891","DOI":"10.1007\/s00253-020-10945-w","article-title":"Helicobacter pylori treatment in the post-antibiotics era-searching for new drug targets","volume":"104","author":"Roszczenko-Jasi\u0144ska","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"12","key":"10.1016\/j.bioorg.2024.107755_b0055","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.3390\/pathogens9121062","article-title":"Biofilm formation as a complex result of virulence and adaptive responses of Helicobacter pylori","volume":"9","author":"Krzy\u017cek","year":"2020","journal-title":"Pathogens."},{"issue":"8","key":"10.1016\/j.bioorg.2024.107755_b0060","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3390\/antibiotics12081260","article-title":"Biofilm of Helicobacter pylori: life cycle, features, and treatment options","volume":"12","author":"Elshenawi","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.bioorg.2024.107755_b0065","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/914791","article-title":"Biofilm formation by Helicobacter pylori and its involvement for antibiotic resistance","author":"Yonezawa","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107755_b0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/antibiotics10010003","article-title":"Biofilms as promoters of bacterial antibiotic resistance and tolerance","volume":"10","author":"Uru\u00e9n","year":"2020","journal-title":"Antibiotics (basel)"},{"key":"10.1016\/j.bioorg.2024.107755_b0075","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.micpath.2019.04.030","article-title":"Effect of Helicobacter pylori biofilm formation on susceptibility to amoxicillin, metronidazole and clarithromycin","volume":"132","author":"Yonezawa","year":"2019","journal-title":"Microb. Pathog."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107755_b0080","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12715","article-title":"Transporters Hp0939 HP0497, and HP0471 participate in intrinsic multidrug resistance and biofilm formation in Helicobacter pylori by enhancing drug efflux","volume":"25","author":"Cai","year":"2020","journal-title":"Helicobacter"},{"issue":"6","key":"10.1016\/j.bioorg.2024.107755_b0085","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3390\/antibiotics9060355","article-title":"Helicobacter pylori biofilm confers antibiotic tolerance in part via a protein-dependent mechanism","volume":"9","author":"Hathroubi","year":"2020","journal-title":"Antibiotics (basel)"},{"issue":"12","key":"10.1016\/j.bioorg.2024.107755_b0090","article-title":"Biofilm formation of Helicobacter pylori in both static and microfluidic conditions is associated with resistance to clarithromycin","volume":"25","author":"Krzy\u017cek","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"15","key":"10.1016\/j.bioorg.2024.107755_b0095","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.2147\/IDR.S357473","article-title":"Helicobacter pylori biofilm-related drug resistance and new developments in its anti-biofilm agents","volume":"5","author":"Hou","year":"2022","journal-title":"Infect Drug Resist."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107755_b0100","doi-asserted-by":"crossref","first-page":"184","DOI":"10.5001\/omj.2019.37","article-title":"WHO global priority pathogens list: a bibliometric analysis of medline-pubmed for knowledge mobilization to infection prevention and control practices in Bahrain","volume":"34","author":"Asokan","year":"2019","journal-title":"Oman Med. J."},{"key":"10.1016\/j.bioorg.2024.107755_b0105","unstructured":"WHO, Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics, 2017."},{"issue":"8","key":"10.1016\/j.bioorg.2024.107755_b0110","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s12272-013-0266-4","article-title":"Anti-Helicobacter pylori xanthones of Garcinia fusca","volume":"37","author":"Nontakham","year":"2014","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.bioorg.2024.107755_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114710","article-title":"Biochemical features and therapeutic potential of \u03b1-Mangostin: mechanism of action, medicinal values, and health benefits","volume":"163","author":"Alam","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2024.107755_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.739658","article-title":"\u03b1-Mangostin induces apoptosis and inhibits metastasis of breast cancer cells via regulating RXR\u03b1-AKT signaling pathway","volume":"12","author":"Zhu","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107755_b0125","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1158\/1535-7163.MCT-20-0787","article-title":"Characterization of novel \u03b1-mangostin and paeonol derivatives with cancer-selective cytotoxicity","volume":"21","author":"Nunna","year":"2022","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bioorg.2024.107755_b0130","article-title":"Antitumor and anti-nematode activities of \u03b1-mangostin","volume":"863","author":"Nunna","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107755_b0135","first-page":"1","article-title":"Antiproliferative, proapoptotic, and potential antifibrotic effects of \u03b1-mangostinin fibroblasts from keloid lesions and normal skin","volume":"1","author":"McFarland","year":"2021","journal-title":"Keloid Res."},{"key":"10.1016\/j.bioorg.2024.107755_b0140","doi-asserted-by":"crossref","first-page":"47","DOI":"10.22159\/ijap.2021v13i4.39065","article-title":"Methods for improving alpha-mangostin solubility: a review","volume":"13","author":"Fajeriyati","year":"2021","journal-title":"Int. J. Appl. Pharm."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107755_b0145","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s11418-023-01718-6","article-title":"Anti-Helicobacter pylori activity of swertianolin, isolated from swertia herb","volume":"77","author":"Suzuki","year":"2023","journal-title":"J. Nat. Med."},{"issue":"11","key":"10.1016\/j.bioorg.2024.107755_b0150","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/ja.2016.36","article-title":"Anti-Helicobacter pylori activity of some newly synthesized derivatives of xanthone","volume":"69","author":"Klesiewicz","year":"2016","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"35","key":"10.1016\/j.bioorg.2024.107755_b0155","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.2174\/1381612826666200417154810","article-title":"An overview of piperazine scaffold as promising nucleus for different therapeutic targets","volume":"26","author":"Sharma","year":"2020","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107755_b0160","doi-asserted-by":"crossref","first-page":"263","DOI":"10.21010\/ajtcam.v14i1.28","article-title":"Inhibitory activity of mangiferin on Helicobacter pylori-induced inflammation in human gastric carcinoma ags cells","volume":"14","author":"Zhang","year":"2016","journal-title":"Afr. J. Tradit. Complement. Altern. Med."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107755_b0165","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.foodchem.2011.10.079","article-title":"Pharmacokinetic study of mangiferin in human plasma after oral administration","volume":"132","author":"Hou","year":"2012","journal-title":"Food Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2024.107755_b0170","first-page":"1539","article-title":"An insight into in vitro antioxidant, antimicrobial, cytotoxic, and apoptosis induction potential of mangiferin, a bioactive compound derived from Mangifera indica","volume":"12","author":"Yehia","year":"2023","journal-title":"Plants (basel)"},{"issue":"7","key":"10.1016\/j.bioorg.2024.107755_b0175","first-page":"498","article-title":"A novel colorimetric broth microdilution method to determine the minimum inhibitory concentration (MIC) of antibiotics and essential oils against Helicobacter pylori","volume":"60","author":"Weseler","year":"2005","journal-title":"Pharmazie"},{"key":"10.1016\/j.bioorg.2024.107755_b0180","unstructured":"European Committee on Antimicrobial Susceptibility Testing, EUCAST clinical breakpoints for Helicobacter pylori. Available from: http:\/\/www.eucast.org\/clinical_breakpoints\/."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107755_b0185","first-page":"63","article-title":"Synthesis and properties of some aminoalkanolic derivatives of xanthone","volume":"54","author":"Marona","year":"1997","journal-title":"Acta Pol. Pharm."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107755_b0190","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3390\/molecules24020314","article-title":"Chiral derivatives of xanthones with antimicrobial activity","volume":"24","author":"Ara\u00fajo","year":"2019","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.bioorg.2024.107755_b0195","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/pca.3131","article-title":"Qualitative and quantitative analysis of the major components in Qinghao Biejia decoction by UPLC-Orbitrap Fusion-MS\/MS and UPLC-QQQ-MS\/MS and evaluation of their antibacterial activities","volume":"33","author":"Cheng","year":"2022","journal-title":"Phytochem. Anal"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107755_b0200","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/pathogens9030184","article-title":"Transformation of Helicobacter pylori into coccoid forms as a challenge for research determining activity of antimicrobial substances","volume":"9","author":"Krzy\u017cek","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.bioorg.2024.107755_b0205","unstructured":"The European Committee on Antimicrobial Susceptibility Testing, Breakpoint tables for interpretation of MICs and zone diameters, Version 13.0, 2023. http:\/\/www.eucast.org."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107755_b0210","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3390\/molecules22020275","article-title":"Anti-bacterial and anti-fungal activity of xanthones obtained via semi-synthetic modification of \u03b1-mangostin from Garcinia mangostana","volume":"22","author":"Narasimhan","year":"2017","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.bioorg.2024.107755_b0215","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"3","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2024.107755_b0220","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1002\/cber.190603904137","article-title":"o-Aminobeuzophenonderivate","volume":"39","author":"Ullmann","year":"1906","journal-title":"BERLIN Deutsche Chemische Gesellschaft"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107755_b0225","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/cbdd.12842","article-title":"Design, synthesis, and anticonvulsant activity of some derivatives of xanthone with aminoalkanol moieties","volume":"89","author":"Waszkielewicz","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"issue":"7","key":"10.1016\/j.bioorg.2024.107755_b0230","first-page":"567","article-title":"Pharmacological properties of some of some aminoalkanolic xanthone derivatives","volume":"56","author":"Marona","year":"2001","journal-title":"Pharmazie"},{"issue":"6","key":"10.1016\/j.bioorg.2024.107755_b0235","first-page":"1281","article-title":"Preparation and properties of some 2-mercaptomethylxanthones","volume":"54","author":"Eckstein","year":"1980","journal-title":"Pol. J. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2024.107755_b0240","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/ardp.19933260805","article-title":"Synthesis and antitumor activity of some new 2-chloroethylnitrosoureas","volume":"326","author":"Filippatos","year":"1993","journal-title":"Arch. Pharm. (Weinheim)"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107755_b0245","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/jps.2600820103","article-title":"\u03b3-Pyrone compounds. IV: Synthesis and antiplatelet effects of mono-and dioxygenated xanthones and xanthonoxypropanolamine","volume":"82","author":"Lin","year":"1993","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107755_b0250","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.bmc.2006.09.026","article-title":"Cholinesterase inhibitors: SAR and enzyme inhibitory activity of 3-[omega-(benzylmethylamino)alkoxy]xanthen-9-ones","volume":"15","author":"Piazzi","year":"2007","journal-title":"Bioorg. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107755_b0255","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1021\/jm00124a012","article-title":"Potential antitumor agents. 58. Synthesis and structure-activity relationships of substituted xanthenone-4-acetic acids active against the colon 38 tumor in vivo","volume":"32","author":"Rewcastle","year":"1989","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107755_b0260","first-page":"219","article-title":"Aminoalkanolic derivatives of xanthone with potential antiepileptic activity","volume":"53","author":"Marona","year":"1998","journal-title":"Pharmazie"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107755_b0265","first-page":"21","article-title":"Synthesis and antimycobacterial assay of some xanthone derivatives","volume":"65","author":"Szkaradek","year":"2008","journal-title":"Acta Pol. Pharm."},{"issue":"21","key":"10.1016\/j.bioorg.2024.107755_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126679","article-title":"Design, synthesis and evaluation of activity and pharmacokinetic profile of new derivatives of xanthone and piperazine in the central nervous system","volume":"29","author":"\u017belaszczyk","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107755_b0275","unstructured":"Clinical and Laboratory Standard Institute (CLSI) Performance Standards for Antimicrobial Susceptibility Testing (32nd edition), CLSI M100, 2022."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107755_b0280","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.3390\/ijms22052695","article-title":"Myricetin as an antivirulence compound interfering with a morphological transformation into coccoid forms and potentiating activity of antibiotics against Helicobacter pylori","volume":"22","author":"Krzy\u017cek","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107755_b0285","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/em.21677","article-title":"International round-robin study on the Ames fluctuation test","volume":"53","author":"Reifferscheid","year":"2012","journal-title":"Environ. Mol. Mutagen."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824006606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824006606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T02:20:23Z","timestamp":1738203623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824006606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":57,"alternative-id":["S0045206824006606"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107755","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibacterial and antibiofilm agents in the group of xanthone derivatives with piperazine moiety active against drug-resistant Helicobacter pylori strains","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107755","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107755"}}